Throughout a medical technology's life cycle, stakeholders may play different roles of varying significance. National agencies are the key actors in regulatory approval, whereas national/regional policy makers determine coverage and reimbursement of innovative technologies. For mature, already adopted technologies, the hospital level has a pivotal role in the rational and appropriate use of resources.
The pivotal role of hospitals in enhancing rational and appropriate use of resources for mature technologies: the case of transcatheter aortic valve implantation
Giuditta Callea
2021
Abstract
Throughout a medical technology's life cycle, stakeholders may play different roles of varying significance. National agencies are the key actors in regulatory approval, whereas national/regional policy makers determine coverage and reimbursement of innovative technologies. For mature, already adopted technologies, the hospital level has a pivotal role in the rational and appropriate use of resources.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2021 Callea ClinicalTherapeutics.pdf
non disponibili
Tipologia:
Pdf editoriale (Publisher's layout)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
88.15 kB
Formato
Adobe PDF
|
88.15 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
